Deferred Tax Assets, Valuation Allowance of NEVRO CORP from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NEVRO CORP quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • NEVRO CORP Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $226,931,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

NEVRO CORP Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $226,931,000 +$20,604,000 +10% 31 Dec 2024 10-K 04 Mar 2025 2024 FY
Q4 2023 $206,327,000 +$5,350,000 +2.7% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q4 2022 $200,977,000 -$111,000 -0.06% 31 Dec 2022 10-K 23 Feb 2024 2023 FY
Q4 2021 $201,088,000 +$36,810,000 +22% 31 Dec 2021 10-K 21 Feb 2023 2022 FY
Q4 2020 $164,278,000 +$32,471,000 +25% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q4 2019 $131,807,000 +$31,060,000 +31% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 $100,747,000 +$12,629,000 +14% 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q4 2017 $88,118,000 +$2,390,000 +2.8% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q4 2016 $85,728,000 +$18,697,000 +28% 31 Dec 2016 10-K 22 Feb 2018 2017 FY
Q4 2015 $67,031,000 +$23,364,000 +54% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q4 2014 $43,667,000 +$9,399,000 +27% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q4 2013 $34,268,000 +$9,956,000 +41% 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q4 2012 $24,312,000 31 Dec 2012 10-K 18 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.